Sun, Qipeng
Huang, Zhengyu
Han, Fei
Zhao, Ming
Cao, Ronghua
Zhao, Daqiang
Hong, Liangqing
Na, Ning
Li, Heng
Miao, Bin
Hu, Jianmin
Meng, Fanhang
Peng, Yanwen
Sun, Qiquan
Clinical trials referenced in this document:
Documents that mention this clinical trial
Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial
https://doi.org/10.1186/s12967-018-1422-x
Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology
https://doi.org/10.1681/asn.2017070781
Funding for this research was provided by:
National Natural Science Foundation of China (81470978, 81279834)
Major Program of Science and Technology Planning Project of Guangdong Province, China (2015B020226005)
Key Project of Natural Science Foundation of Guangdong Province, China (2015A030311040)
Leading Scientific, Technical and Innovation Talents of Guangdong Special Support Program (510204006192)
Article History
Received: 27 November 2017
Accepted: 20 February 2018
First Online: 7 March 2018